Login
Home > Event Calendar

<span style= " />
Untitled Document

 

 

SRA Workshop on Scientific Methods for
Evaluating Endocrine Disruptor Screening Program Data and Estimating Dose-Response

Sunday, December 6, 2009

8:00 a.m. to 5:00 p.m.
Lunch Included

Renaissance Inner Harbor Hotel

202 E. Pratt Ave.
Baltimore, MD
Sponsored by

The Society for Risk Analysis
and
Regulatory Checkbook

Organized by
Richard Belzer
Regulatory Checkbook
703-780-1850
Belzer@RegulatoryCheckbook.org
Steven Lewis
Integrative Policy & Science
908-689-8644
stevenclewis@alumni.indiana.edu

Law enacted in 1996 (codified at 21 U.S.C. 346a(p)) directs the U.S. Environmental Protection Agency to "develop a screening program, using appropriate validated test systems and other scientifically relevant information, to determine whether certain substances may have an effect in humans that is similar to an effect produced by a naturally occurring estrogen." EPA's implementation of this directive has proved challenging for a number of reasons, including the difficulty of defining "adverse" endocrine effects in humans (mere perturbations of the endocrine system being routine and normal biochemical events), and devising and validating appropriate toxicological test systems that are sufficiently sensitive and specific to achieve the statutory goal.

EPA's Endocrine Disruptor Screening Program (EDSP) consists of a two-tiered testing strategy supplemented, as required by law, with "other relevant scientific information." Tier 1 will screen for potential adverse effects and Tier 2 will characterize human dose-response for (adverse) endocrine effects. However, EPA does not yet have a scientific weight-of-evidence framework for evaluating Tier 1 data and "other scientifically relevant information," both of which the Agency must use to determine whether a substance subjected to Tier 1 testing must proceed to Tier 2.

This workshop has two objectives. First, the morning session will evaluate the Tier 1 test battery to ascertain (a) whether Tier 1 data can satisfy statutory criteria; and (b) if so, how outputs from Tier 1 and "other relevant scientific information" can be used to develop a (minimally) ordinal or (desirably) cardinal ranking of human endocrine effects that is scientific, transparent, reproducible, and objective.

Second, the afternoon session will focus on selecting and designing "appropriate validated test systems" for estimating dose-response. This is a novel assignment because no established methods now exist for discriminating between adverse and nonadverse endocrine effects and objectively estimating human dose-response. For this reason, the EDSP Tier 2 provides a novel opportunity for innovative scientific work in toxicology, modeling and biostatistics. Registrants will have ample opportunity to participate. The workshop will produce a report suitable for submission to a peer reviewed journal.

Lunch is included.

To register, please go to the SRA website. Space is limited. For hotel reservations, click here.

Workshop Agenda

Time

Speaker/
Discussion Leader

Topic

0800

Richard Belzer
Regulatory Checkbook
Mt. Vernon, VA

  • Introduction to the Workshop

  • Introduction to the AM Session

    • Statutory Framework: Federal Food, Drug and Cosmetic Act (21 U.S.C 346a(p)

    • Statutory Framework: Paperwork Reduction Act (44 U.S.C. 3501 et seq.)

0830

Steven Lewis
Integrative Policy & Science
Washington, NJ

Theories of Validity in Science

0845

Sue Marty
Dow Chemical Company

Sensitivity, Selectivity, Variability and Uncertainty in Tier 1 Assays

0930

Tom Vidmar
BioSTAT Consultants
Kalamazoo, MI

Using Tier 1 Data to Rank Chemicals for Endocrine Effects in Humans

1015

Coffee Break

 

1030

Warner North
Northworks
Belmont, CA

Applying "Value of Information" (VOI) Principles to Tier 1 Test Data and "Other Scientifically Relevant Information"

1100

Ray Witorsch
Medical College of Virginia
Virginia Commonwealth University
Richmond, V
A

Can Tier 1 Test Data Inform Priority-Setting for Human Health Risk Assessment?

1145

[Interactive]

An ad hoc Experiment in Ranking Tier 1 Data

1230

Buffet Lunch

Included in Registration

1330

Richard Belzer
Regulatory Checkbook
Mt. Vernon, VA

  • Introduction to the PM session

  • Statutory Framework: Information Quality Act
    (44 U.S.C 3516 note)

1400

Harvey Clewell III
The Hamner Institutes
Research Triangle Park, NC

Innovative Methods for Assessing Human Health Risks from Endocrine-Active Chemicals

1445

Chris Borgert
Applied Pharmacology and Toxicology
Gainesville, FL

Bob Golden*
ToxLogic
Potomac, MD

1530

Coffee Break

1545

Discussants

Resha Putzrath
U.S. Navy
Portsmouth, VA

Ray Witorsch
Medical College of Virginia
Virginia Commonwealth University
Richmond, V
A

1630

Richard Belzer
Regulatory Checkbook
Mt. Vernon, VA

  • Summing Up

  • Next Steps

1700

Adjournment

 

* Invited

 

Date: 6 December 2009